跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ST-6
首页
药物
ST-6
ST-6
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
3Ag + mi3 protein nanoparticles for preventing and treating BVD and IBR as well as preparation method and application of 3Ag + mi3 protein nanoparticles
申请人: UNIV NINGXIA
优先权: 2025
CN
CHEMICAL TREATMENT OF RECOVERED LIQUID CAPROLACTAM
申请人: BASF SE
优先权: 2024
CN
WO
2 件公开
Medicinal composition for treating hyperosteogency
申请人: ZHANG NAIGONG
优先权: 2006
CN
Medicine for treating heatstroke and its preparation method
申请人: XU MINGXUE
优先权: 2005
CN
枯草芽孢杆菌ST-1086的用途
申请人: 广东双骏生物科技有限公司
优先权: 2026
CN
Method for generating porcine pseudorabies virus by culturing ST cell in microcarrier of bioreactor
申请人: HARBIN PHARMACEUTICAL GROUP BIO VACCINE CO LTD
优先权: 2011
CN
Preparation method and application of porcine delta coronavirus inactivated vaccine
申请人: ZHEJIANG HONGSHENG BIOTECHNOLOGY CO LTD
优先权: 2022
CN
Targeted EL-HN or EHc double-domain antibody and self-assembled antibody nanocage thereof
申请人: INST MILITARY MEDICINE ACADEMY MILITARY SCIENCES PLA
优先权: 2025
CN
药物
反馈